Nicholas Grund

Chief Commercial Officer, Akebia Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Feb 2, 2026

Companies

Akebia Therapeutics, Inc.Chief Commercial Officer −$0.1M

Trades

AKBA Sold 84,829 shares at $1.39 · planned $0.1M Feb 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.